Table Info

Table 1.

Age, sex, and proportion of HTN in patients in the studies

Authors	HTN			HTN and HFpEF			Control
Authors	Age	Sex (% M)	% HTN	Age	Sex (% M)	% HTN	Age	Sex (% M)	% HTN
Stoichescu-Hogea et al. [26]	61	52	100	63	67.7	85.5	60	55	0
He et al. [19]	51	56	100	56	62	100	49	50	0
Tanacli et al. [17]	NA	NA	NA	73	60	70	68	60	0
Mordi et al. [24]	70	77	100	71	32	76	68	50	0
Liu et al. [20]	62	NA	93	61	NA	82	58	NA	0
Minatoguchi et al. [25]	70	59	100	75	60	100	69	61	0
Gregorova et al. [22]	63.3	26.3	89.5	68.5	30.4	87	63	38.1	NA
Kraigher-Krainer et al. [21]	71	39	100	72	39	90	69	32	0

NA: not available; M: male

Declarations

Author contributions

The author contributed solely to the work.

Conflicts of interest

The author declares that he has no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Not applicable.

Funding

Not applicable.

Copyright

References

Drazner MH. The progression of hypertensive heart disease. Circulation. 2011;123:327–34. [DOI] [PubMed]

Reddy YNV, Borlaug BA. Heart failure with preserved ejection fraction. Curr Probl Cardiol. 2016;41:145–88. [DOI] [PubMed]

Lam CS, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13:18–28. [DOI] [PubMed] [PMC]

Flachskampf FA, Blankstein R, Grayburn PA, Kramer CM, Kwong RYK, Marwick TH, et al. Global longitudinal shortening: a positive step towards reducing confusion surrounding global longitudinal strain. JACC Cardiovasc Imaging. 2019;12:1566–7. [DOI] [PubMed] [PMC]

Torrent-Guasp F, Ballester M, Buckberg GD, Carreras F, Flotats A, Carrió I, et al. Spatial orientation of the ventricular muscle band: physiologic contribution and surgical implications. J Thorac Cardiovasc Surg. 2001;122:389–92. [DOI] [PubMed]

Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J. 1981;45:248–63. [DOI] [PubMed] [PMC]

Bogaert J, Rademakers FE. Regional nonuniformity of normal adult human left ventricle. Am J Physiol Heart Circ Physiol. 2001;280:H610–20. [DOI] [PubMed]

Collier P, Phelan D, Klein A. A test in context: myocardial strain measured by speckle-tracking echocardiography. J Am Coll Cardiol. 2017;69:1043–56. [DOI] [PubMed]

Voigt JU, Cvijic M. 2- and 3-dimensional myocardial strain in cardiac health and disease. JACC Cardiovasc Imaging. 2019;12:1849–63. [DOI] [PubMed]

10.

Scatteia A, Baritussio A, Bucciarelli-Ducci C. Strain imaging using cardiac magnetic resonance. Heart Fail Rev. 2017;22:465–76. [DOI] [PubMed] [PMC]

11.

Adamu U, Schmitz F, Becker M, Kelm M, Hoffmann R. Advanced speckle tracking echocardiography allowing a three-myocardial layer-specific analysis of deformation parameters. Eur J Echocardiogr. 2009;10:303–8. [DOI] [PubMed]

12.

Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47:789–93. [DOI] [PubMed]

13.

Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100:1673–80. [DOI] [PubMed]

14.

Kato T, Harada T, Kagami K, Obokata M. The roles of global longitudinal strain imaging in contemporary clinical cardiology. J Med Ultrason. 2022;49:175–85. [DOI] [PubMed]

15.

Bottinor WJ, Migliore CK, Lenneman CA, Stoddard MF. Echocardiographic assessment of cardiotoxic effects of cancer therapy. Curr Cardiol Rep. 2016;18:99. [DOI] [PubMed]

16.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. [DOI] [PubMed] [PMC]

17.

Tanacli R, Hashemi D, Neye M, Motzkus LA, Blum M, Tahirovic E, et al. Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction. ESC Heart Fail. 2020;7:3240–5. [DOI] [PubMed] [PMC]

18.

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester: John Wiley & Sons; 2019.

19.

He J, Sirajuddin A, Li S, Zhuang B, Xu J, Zhou D, et al. Heart failure with preserved ejection fraction in hypertension patients: a myocardial MR strain study. J Magn Reson Imaging. 2021;53:527–39. [DOI] [PubMed]

20.

Liu S, Guan Z, Jin X, Meng P, Wang Y, Zheng X, et al. Left ventricular diastolic and systolic dyssynchrony and dysfunction in heart failure with preserved ejection fraction and a narrow QRS complex. Int J Med Sci. 2018;15:108–14. [DOI] [PubMed] [PMC]

21.

Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, et al.; PARAMOUNT Investigators. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2014;63:447–56. Erratum in: J Am Coll Cardiol. 2014;64:335. [DOI] [PubMed] [PMC]

22.

Gregorova Z, Meluzin J, Stepanova R, Sitar J, Podrouzkova H, Spinarova L. Longitudinal, circumferential and radial systolic left ventricular function in patients with heart failure and preserved ejection fraction. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016;160:385–92. [DOI] [PubMed]

23.

Satoh T, Wang L, Espinosa-Diez C, Wang B, Hahn SA, Noda K, et al. Metabolic syndrome mediates ROS-miR-193b-NFYA-dependent downregulation of soluble guanylate cyclase and contributes to exercise-induced pulmonary hypertension in heart failure with preserved ejection fraction. Circulation. 2021;144:615–37. [DOI] [PubMed] [PMC]

24.

Mordi IR, Singh S, Rudd A, Srinivasan J, Frenneaux M, Tzemos N, et al. Comprehensive echocardiographic and cardiac magnetic resonance evaluation differentiates among heart failure with preserved ejection fraction patients, hypertensive patients, and healthy control subjects. JACC Cardiovasc Imaging. 2018;11:577–85. Erratum in: JACC Cardiovasc Imaging. 2019;12:576. [DOI] [PubMed]

25.

Minatoguchi S, Kawasaki M, Tanaka R, Yoshizane T, Ono K, Saeki M, et al. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates. Heart Vessels. 2017;32:1202–13. [DOI] [PubMed]

26.

Stoichescu-Hogea G, Buleu FN, Christodorescu R, Sosdean R, Tudor A, Ember A, et al. Contribution of global and regional longitudinal strain for clinical assessment of HFpEF in coronary and hypertensive patients. Medicina (Kaunas). 2021;57:1372. [DOI] [PubMed] [PMC]

27.

Culwell NM, Bonagura JD, Schober KE. Comparison of echocardiographic indices of myocardial strain with invasive measurements of left ventricular systolic function in anesthetized healthy dogs. Am J Vet Res. 2011;72:650–60. [DOI] [PubMed]

28.

Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S. Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J. 2016;37:1196–207. [DOI] [PubMed] [PMC]

29.

Grenne B, Eek C, Sjøli B, Skulstad H, Aakhus S, Smiseth OA, et al. Changes of myocardial function in patients with non-ST-elevation acute coronary syndrome awaiting coronary angiography. Am J Cardiol. 2010;105:1212–8. [DOI] [PubMed]

30.

Biering-Sørensen T, Shah SJ, Anand I, Sweitzer N, Claggett B, Liu L, et al. Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fraction. Eur J Heart Fail. 2017;19:1043–52. [DOI] [PubMed] [PMC]

31.

Hensen LCR, Goossens K, Delgado V, Abou R, Rotmans JI, Jukema JW, et al. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction. Eur J Heart Fail. 2018;20:560–8. [DOI] [PubMed]

32.

Maciver DH. The relative impact of circumferential and longitudinal shortening on left ventricular ejection fraction and stroke volume. Exp Clin Cardiol. 2012;17:5–11. [PubMed] [PMC]

33.

Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr. 2008;21:1138–44. [DOI] [PubMed]

34.

Mordi I, Bezerra H, Carrick D, Tzemos N. The combined incremental prognostic value of LVEF, late gadolinium enhancement, and global circumferential strain assessed by CMR. JACC Cardiovasc Imaging. 2015;8:540–9. [DOI] [PubMed]

35.

Szelényi Z, Fazakas Á, Szénási G, Tegze N, Fekete B, Molvarec A, et al. The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction. J Hypertens. 2015;33:1962–9. [DOI] [PubMed]

36.

Henein M, Mörner S, Lindmark K, Lindqvist P. Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension. Int J Cardiol. 2013;168:1088–93. [DOI] [PubMed]

37.

Carabello BA. Evolution of the study of left ventricular function: everything old is new again. Circulation. 2002;105:2701–3. [DOI] [PubMed]

38.

Marwick TH. Ejection fraction pros and cons: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:2360–79. [DOI] [PubMed]

39.

Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation. 2005;111:2306–12. [DOI] [PubMed]

40.

Borlaug BA, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2009;54:410–8. [DOI] [PubMed] [PMC]

41.

Rabkin SW. Heart failure with reduced ejection fraction and diastolic dysfunction (HrEFwDD): time for a new clinical entity. Int J Cardiol. 2022;363:123–4. [DOI] [PubMed]

42.

Koshizuka R, Ishizu T, Kameda Y, Kawamura R, Seo Y, Aonuma K. Longitudinal strain impairment as a marker of the progression of heart failure with preserved ejection fraction in a rat model. J Am Soc Echocardiogr. 2013;26:316–23. [DOI] [PubMed]

43.

Blessberger H, Binder T. Non-invasive imaging: two dimensional speckle tracking echocardiography: basic principles. Heart. 2010;96:716–22. [DOI] [PubMed]

44.

Oki T, Miyoshi H, Oishi Y, Mizuguchi Y, Ara N, Iuchi A. The impact of hypertension as a road to heart failure with preserved ejection fraction: diagnostic value of two-dimensional speckle tracking echocardiography for the early impairment of left atrial-left ventricular-arterial coupling. Curr Hypertens Rev. 2014;10:177–88. [DOI] [PubMed]

45.

Rabkin SW. Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: a systematic review focused on defining high risk phenogroups. EXCLI J. 2022;21:487–518. [DOI] [PubMed] [PMC]

46.

Katz DH, Deo RC, Aguilar FG, Selvaraj S, Martinez EE, Beussink-Nelson L, et al. Phenomapping for the identification of hypertensive patients with the myocardial substrate for heart failure with preserved ejection fraction. J Cardiovasc Transl Res. 2017;10:275–84. [DOI] [PubMed]